South Africa wants to start virus vaccination next month

Credit: CC0 public domain

South Africa, which was hit hard by the second wave of coronavirus, wants to get its first vaccination next month, the health minister announced on Sunday.

In recent weeks, the South African government has been criticized, especially by health experts, for delaying the start of its vaccination program for COVID-19.

Dr. Zwelli Mukize said at a news conference that he was “aiming for February,” but before that he needs to end negotiations with vaccine makers such as Pfizer, Moderna and AstraZeneca and laboratories in Russia and China. Warned.

To finance the vaccine program, the government plans to seek help from the private sector and major national health insurance companies.

South Africa also participates in Covax, the World Health Organization’s global vaccine distribution mechanism.

Last week, the government paid a € 15.8 million deposit to enter Covax, a mechanism for the equitable distribution of vaccines established by the United Nations World Health Organization.

However, South Africa, the most devastating country on the African continent, does not expect to receive its first vaccination under its program until the second quarter of this year.

“It’s clear that the second wave we’re experiencing is affecting us to a higher level than before,” the minister said.

“The only way to deal with COVID-19, not only in South Africa, but around the world, is to provide immunity by vaccination,” Mkhize added.

The country’s first primary goal is to vaccinate 67 percent of the 59 million population to achieve sufficient herd immunity to stop the spread of the virus.

On Thursday, South Africa registered a record 18,000 new cases in 24 hours.

It is also the first African country to surpass 1 million registered COVID-19 cases.

Follow the latest news about the outbreak of coronavirus (COVID-19)

© 2021 AFP

Quote: South Africa wants to start virus vaccination next month (January 3, 2021). Obtained from https: // on January 3, 2021

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.

Back to top button